| Year |
Citation |
Score |
| 2023 |
Ho K, Zhu D, Gupta K, Loloi J, Abramson M, Watts K, Agalliu I, Sankin A. Performance of cognitive vs. image-guided fusion biopsy for detection of overall and clinically significant prostate cancer in a multiethnic population. Urologic Oncology. PMID 38114350 DOI: 10.1016/j.urolonc.2023.11.005 |
0.352 |
|
| 2023 |
Hoffmann TJ, Graff RE, Madduri RK, Rodriguez AA, Cario CL, Feng K, Jiang Y, Wang A, Klein RJ, Pierce BL, Eggener S, Tong L, Blot W, Long J, Rebbeck T, ... ... Agalliu I, et al. Genome-wide association study of prostate-specific antigen levels in 392,522 men identifies new loci and improves cross-ancestry prediction. Medrxiv : the Preprint Server For Health Sciences. PMID 37961155 DOI: 10.1101/2023.10.27.23297676 |
0.319 |
|
| 2023 |
Patel RD, Zhu M, Dave P, Agalliu I, Trinh QD, Watts KL. Predictors of Timely and Delayed Urological Evaluation Following Referral for Elevated Prostate-specific Antigen in a Diverse, Urban, High-risk Population. Urology Practice. 101097UPJ00000000000. PMID 37103521 DOI: 10.1097/UPJ.0000000000000405 |
0.307 |
|
| 2022 |
Kim MS, Naidoo D, Hazra U, Quiver MH, Chen WC, Simonti CN, Kachambwa P, Harlemon M, Agalliu I, Baichoo S, Fernandez P, Hsing AW, Jalloh M, Gueye SM, Niang L, et al. Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa. Genome Biology. 23: 194. PMID 36100952 DOI: 10.1186/s13059-022-02766-z |
0.44 |
|
| 2022 |
Zhu D, Toker M, Shyr W, Fram E, Watts KL, Agalliu I. Association of Obesity and Diabetes With Prostate Cancer Risk Groups in a Multiethnic Population. Clinical Genitourinary Cancer. PMID 35193833 DOI: 10.1016/j.clgc.2022.01.016 |
0.377 |
|
| 2021 |
Zhu D, Shyr W, Toker M, Fram E, Cheng J, Kovac EZ, Agalliu I, Aboumohamed A, Watts KL. The impact of surgical downgrading on prostate cancer recurrence: systematic review and analysis of a multiethnic population. World Journal of Urology. PMID 34850269 DOI: 10.1007/s00345-021-03892-2 |
0.362 |
|
| 2021 |
Agalliu I, Lin WJ, Zhang JS, Jacobson JS, Rohan TE, Adusei B, Snyper NYF, Andrews C, Sidahmed E, Mensah JE, Biritwum R, Adjei AA, Okyne V, Ainuson-Quampah J, Fernandez P, et al. Overall and central obesity and prostate cancer risk in African men. Cancer Causes & Control : Ccc. PMID 34783926 DOI: 10.1007/s10552-021-01515-0 |
0.371 |
|
| 2021 |
Hines L, Zhu D, DeMasi M, Babar M, Chernyak V, Kovac EZ, Aboumohamed A, Sankin A, Agalliu I, Watts KL. A Comparison of Image-Guided Targeted Prostate Biopsy Outcomes by PI-RADS Score and Ethnicity in a Diverse, Multiethnic Population. The Journal of Urology. 101097JU000000000000. PMID 33881932 DOI: 10.1097/JU.0000000000001810 |
0.319 |
|
| 2021 |
Zhu D, Srivastava A, Agalliu I, Fram E, Kovac EZ, Aboumohamed A, Schoenberg MP, Sankin AI. Finasteride Use and Risk of Bladder Cancer in a Multiethnic Population. The Journal of Urology. 101097JU000000000000. PMID 33617325 DOI: 10.1097/JU.0000000000001694 |
0.306 |
|
| 2020 |
Hurwitz LM, Agalliu I, Albanes D, Barry KH, Berndt SI, Cai Q, Chen C, Cheng I, Genkinger JM, Giles GG, Huang J, Joshu CE, Key TJ, Knutsen S, Koutros S, et al. Recommended definitions of aggressive prostate cancer for etiologic epidemiologic research. Journal of the National Cancer Institute. PMID 33010161 DOI: 10.1093/jnci/djaa154 |
0.391 |
|
| 2020 |
Harlemon M, Ajayi O, Kachambwa P, Kim MS, Simonti CN, Quiver MH, Petersen DC, Mittal A, Fernandez PW, Hsing AW, Baichoo S, Agalliu I, Jalloh M, Gueye SM, Snyper NYF, et al. A custom genotyping array reveals population-level heterogeneity for the genetic risks of prostate cancer and other cancers in Africa. Cancer Research. PMID 32393663 DOI: 10.1158/0008-5472.CAN-19-2165 |
0.43 |
|
| 2020 |
Zahalka AH, Fram E, Lin W, Mohn L, Frenette PS, Agalliu I, Watts KL. Use of beta-blocker types and risk of incident prostate cancer in a multiethnic population. Urologic Oncology. PMID 32307329 DOI: 10.1016/J.Urolonc.2020.03.024 |
0.373 |
|
| 2019 |
Zahalka* A, Fram E, Lin W, Mohn L, Frenette P, Agalliu I, Watts K. MP48-16 ATENOLOL REDUCES INCIDENT LOW AND INTERMEDIATE RISK PROSTATE CANCER Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556400.17034.02 |
0.413 |
|
| 2018 |
Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, ... ... Agalliu I, et al. Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate. Journal of Global Oncology. 1-14. PMID 30260755 DOI: 10.1200/Jgo.18.00063 |
0.392 |
|
| 2017 |
Llukani E, Katz BF, Agalliu I, Lightfoot A, Yu SS, Kathrins M, Lee Z, Su YK, Monahan Agnew K, McGill A, Eun DD, Lee DI. Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancer. Prostate International. 5: 17-23. PMID 28352619 DOI: 10.1016/j.prnil.2016.12.003 |
0.353 |
|
| 2016 |
Adedimeji AA, Lounsbury D, Popoola O, Asuzu C, Lawal A, Oladoyin V, Crifase C, Agalliu I, Shankar V, Adebiyi A. Improving outcomes in cancer diagnosis, prevention and control: barriers, facilitators and the need for health literacy in Ibadan Nigeria. Psycho-Oncology. PMID 27218238 DOI: 10.1002/Pon.4158 |
0.329 |
|
| 2015 |
Palma A, Lounsbury DW, Schlecht NF, Agalliu I. A System Dynamics Model of Serum Prostate-Specific Antigen Screening for Prostate Cancer. American Journal of Epidemiology. PMID 26702631 DOI: 10.1093/aje/kwv262 |
0.382 |
|
| 2015 |
Agalliu I, Adebiyi AO, Lounsbury DW, Popoola O, Jinadu K, Amodu O, Paul S, Adedimeji A, Asuzu C, Asuzu M, Ogunbiyi OJ, Rohan T, Shittu OB. The feasibility of epidemiological research on prostate cancer in African men in Ibadan, Nigeria. Bmc Public Health. 15: 425. PMID 25927535 DOI: 10.1186/S12889-015-1754-X |
0.445 |
|
| 2015 |
Agalliu I, Williams S, Adler B, Androga L, Siev M, Lin J, Xue X, Huang G, Strickler HD, Ghavamian R. The impact of obesity on prostate cancer recurrence observed after exclusion of diabetics. Cancer Causes & Control : Ccc. 26: 821-30. PMID 25771797 DOI: 10.1007/s10552-015-0554-z |
0.346 |
|
| 2015 |
Beebe-Dimmer JL, Yee C, Cote ML, Petrucelli N, Palmer N, Bock C, Lane D, Agalliu I, Stefanick ML, Simon MS. Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study. Cancer. 121: 1265-72. PMID 25754547 DOI: 10.1002/Cncr.29075 |
0.466 |
|
| 2013 |
Desai P, Chlebowski R, Cauley JA, Manson JE, Wu C, Martin LW, Jay A, Bock C, Cote M, Petrucelli N, Rosenberg CA, Peters U, Agalliu I, Budrys N, Abdul-Hussein M, et al. Prospective analysis of association between statin use and breast cancer risk in the women's health initiative. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1868-76. PMID 23975947 DOI: 10.1158/1055-9965.Epi-13-0562 |
0.394 |
|
| 2013 |
Schooling CM, Sembajwe G, Agalliu I. Re: Christina G. Jespersen, Mette Nørgaard, Michael Borre. Androgen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort study. European Urology. 64: e59-60. PMID 23623050 DOI: 10.1016/j.eururo.2013.04.017 |
0.336 |
|
| 2013 |
Agalliu I, Wang Z, Wang T, Dunn A, Parikh H, Myers T, Burk RD, Amundadottir L. Characterization of SNPs associated with prostate cancer in men of Ashkenazic descent from the set of GWAS identified SNPs: impact of cancer family history and cumulative SNP risk prediction. Plos One. 8: e60083. PMID 23573233 DOI: 10.1371/journal.pone.0060083 |
0.403 |
|
| 2013 |
Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, ... ... Agalliu I, et al. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes & Control : Ccc. 24: 595-602. PMID 23334854 DOI: 10.1007/S10552-012-0138-0 |
0.306 |
|
| 2012 |
Hakimi AA, Agalliu I, Ho GY, Ghavamian R, Yu C, Kattan MW, Rabbani F. Detection of prostate cancer in an ethnically diverse, disadvantaged population with multiple prostate specific antigen measurements before biopsy. The Journal of Urology. 187: 1234-40. PMID 22335862 DOI: 10.1016/J.Juro.2011.11.090 |
0.405 |
|
| 2012 |
Wang Z, Parikh H, Jia J, Myers T, Yeager M, Jacobs KB, Hutchinson A, Burdett L, Ghosh A, Thun MJ, Gapstur SM, Ryan Diver W, Virtamo J, Albanes D, Cancel-Tassin G, ... ... Agalliu I, et al. Y chromosome haplogroups and prostate cancer in populations of European and Ashkenazi Jewish ancestry. Human Genetics. 131: 1173-85. PMID 22271044 DOI: 10.1007/s00439-012-1139-5 |
0.44 |
|
| 2011 |
Agalliu I, Costello S, Applebaum KM, Ray RM, Astrakianakis G, Gao DL, Thomas DB, Checkoway H, Eisen EA. Risk of lung cancer in relation to contiguous windows of endotoxin exposure among female textile workers in Shanghai. Cancer Causes & Control : Ccc. 22: 1397-404. PMID 21732048 DOI: 10.1007/S10552-011-9812-X |
0.569 |
|
| 2011 |
Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, et al. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 32: 1361-5. PMID 21705483 DOI: 10.1093/Carcin/Bgr119 |
0.466 |
|
| 2011 |
Djavan B, Laze J, Eckersberger E, Finkelstein J, Agalliu I, Lepor H. The short-term use of erythropoetin-stimulating agents: impact on the biochemical recurrence of prostate cancer. Bju International. 108: 1582-7. PMID 21443653 DOI: 10.1111/j.1464-410X.2011.10173.x |
0.354 |
|
| 2011 |
Agalliu I, Kirsh VA, Kreiger N, Soskolne CL, Rohan TE. Oxidative balance score and risk of prostate cancer: results from a case-cohort study. Cancer Epidemiology. 35: 353-61. PMID 21145797 DOI: 10.1016/J.Canep.2010.11.002 |
0.414 |
|
| 2010 |
Agalliu I, Leanza SM, Smith L, Trent JM, Carpten JD, Bailey-Wilson JE, Burk RD. Contribution of HPC1 (RNASEL) and HPCX variants to prostate cancer in a founder population. The Prostate. 70: 1716-27. PMID 20564318 DOI: 10.1002/Pros.21207 |
0.415 |
|
| 2010 |
Jacobs EJ, Chanock SJ, Fuchs CS, Lacroix A, McWilliams RR, Steplowski E, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Gross M, Helzlsouer K, Petersen G, Zheng W, Agalliu I, Allen NE, et al. Family history of cancer and risk of pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). International Journal of Cancer. Journal International Du Cancer. 127: 1421-8. PMID 20049842 DOI: 10.1002/Ijc.25148 |
0.406 |
|
| 2010 |
Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes & Control : Ccc. 21: 289-300. PMID 19902366 DOI: 10.1007/S10552-009-9461-5 |
0.303 |
|
| 2009 |
Agalliu I, Gern R, Leanza S, Burk RD. Associations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1112-20. PMID 19188187 DOI: 10.1158/1078-0432.CCR-08-1822 |
0.402 |
|
| 2008 |
FitzGerald LM, Agalliu I, Johnson K, Miller MA, Kwon EM, Hurtado-Coll A, Fazli L, Rajput AB, Gleave ME, Cox ME, Ostrander EA, Stanford JL, Huntsman DG. Association of TMPRSS2-ERG gene fusion with clinical characteristics and outcomes: results from a population-based study of prostate cancer. Bmc Cancer. 8: 230. PMID 18694509 DOI: 10.1186/1471-2407-8-230 |
0.406 |
|
| 2008 |
Agalliu I, Salinas CA, Hansten PD, Ostrander EA, Stanford JL. Statin use and risk of prostate cancer: results from a population-based epidemiologic study. American Journal of Epidemiology. 168: 250-60. PMID 18556686 DOI: 10.1093/Aje/Kwn141 |
0.503 |
|
| 2008 |
Agalliu I, Suuriniemi M, Prokunina-Olsson L, Johanneson B, Collins FS, Stanford JL, Ostrander EA. Evaluation of a variant in the transcription factor 7-like 2 (TCF7L2) gene and prostate cancer risk in a population-based study. The Prostate. 68: 740-7. PMID 18302196 DOI: 10.1002/Pros.20732 |
0.511 |
|
| 2008 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Cigarette smoking and prostate cancer-specific mortality following diagnosis in middle-aged men. Cancer Causes & Control : Ccc. 19: 25-31. PMID 17906959 DOI: 10.1007/S10552-007-9066-9 |
0.496 |
|
| 2007 |
Agalliu I, Karlins E, Kwon EM, Iwasaki LM, Diamond A, Ostrander EA, Stanford JL. Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancer. British Journal of Cancer. 97: 826-31. PMID 17700570 DOI: 10.1038/Sj.Bjc.6603929 |
0.457 |
|
| 2007 |
Agalliu I, Weiss NS, Lin DW, Stanford JL. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men. Cancer Causes & Control : Ccc. 18: 931-7. PMID 17641982 DOI: 10.1016/J.Juro.2007.10.044 |
0.471 |
|
| 2007 |
Suuriniemi M, Agalliu I, Schaid DJ, Johanneson B, McDonnell SK, Iwasaki L, Stanford JL, Ostrander EA. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 809-14. PMID 17416775 DOI: 10.1158/1055-9965.Epi-06-1049 |
0.522 |
|
| 2007 |
Gong Z, Agalliu I, Lin DW, Stanford JL, Kristal AR. Obesity is associated with increased risks of prostate cancer metastasis and death after initial cancer diagnosis in middle-aged men. Cancer. 109: 1192-202. PMID 17311344 DOI: 10.1002/Cncr.22534 |
0.517 |
|
| 2007 |
Agalliu I, Kwon EM, Zadory D, McIntosh L, Thompson J, Stanford JL, Ostrander EA. Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 839-43. PMID 17289875 DOI: 10.1158/1078-0432.Ccr-06-2164 |
0.495 |
|
| 2006 |
Agalliu I, Lin DW, Salinas CA, Feng Z, Stanford JL. Polymorphisms in the glutathione S-transferase M1, T1, and P1 genes and prostate cancer prognosis. The Prostate. 66: 1535-41. PMID 16921513 DOI: 10.1002/Pros.20491 |
0.455 |
|
| 2006 |
Salinas CA, Agalliu I, Stanford JL, Lin DW. Statins and the risk of cancer. Jama. 295: 2721; author reply 2. PMID 16788124 DOI: 10.1001/Jama.295.23.2721-A |
0.474 |
|
| 2006 |
Agalliu I, Langeberg WJ, Lampe JW, Salinas CA, Stanford JL. Glutathione S-transferase M1, T1, and P1 polymorphisms and prostate cancer risk in middle-aged men. The Prostate. 66: 146-56. PMID 16173036 DOI: 10.1002/Pros.20305 |
0.483 |
|
| 2005 |
Agalliu I, Kriebel D, Quinn MM, Wegman DH, Eisen EA. Prostate cancer incidence in relation to time windows of exposure to metalworking fluids in the auto industry. Epidemiology (Cambridge, Mass.). 16: 664-71. PMID 16135943 DOI: 10.1097/01.Ede.0000173266.49104.Bb |
0.644 |
|
| 2005 |
Agalliu I, Eisen EA, Kriebel D, Quinn MM, Wegman DH. A biological approach to characterizing exposure to metalworking fluids and risk of prostate cancer (United States). Cancer Causes & Control : Ccc. 16: 323-31. PMID 15953975 DOI: 10.1007/S10552-004-4323-7 |
0.647 |
|
| 2004 |
Eisen EA, Agalliu I, Thurston SW, Coull BA, Checkoway H. Smoothing in occupational cohort studies: an illustration based on penalised splines. Occupational and Environmental Medicine. 61: 854-60. PMID 15377772 DOI: 10.1136/Oem.2004.013136 |
0.532 |
|
| 2003 |
Agalliu I, Eisen EA, Hauser R, Redlich CA, Stowe MH, Cullen MR, Wegman DH, Christiani DC, Kennedy SM. Truncating the dose range for methacholine challenge tests: three occupational studies. Journal of Occupational and Environmental Medicine / American College of Occupational and Environmental Medicine. 45: 841-7. PMID 12915785 DOI: 10.1097/01.Jom.0000083031.56116.53 |
0.454 |
|
| Show low-probability matches. |